ArticleGut and liver2015

Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon α Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection.

Fahmy T Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.